Results for tag: "Arteriovenous Fistula Drug"

The Arteriovenous Fistula Drug market is a subset of the Cardiovascular Drugs market. It is composed of drugs used to treat arteriovenous fistulas, which are abnormal connections between arteries and veins. These drugs are used to reduce the risk of complications associated with the fistulas, such as aneurysms, thrombosis, and embolism. They may also be used to reduce the risk of infection and to improve the patient's quality of life. Common drugs used to treat arteriovenous fistulas include anticoagulants, antiplatelet agents, and vasodilators. Some companies in the Arteriovenous Fistula Drug market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. Show Less Read more